440
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Is there any room for therapeutic vaccination against the HIV-1/AIDS?

Pages 1539-1544 | Received 15 Mar 2013, Accepted 22 Mar 2013, Published online: 09 Apr 2013

References

  • UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva, Switzerland, 2012.
  • Guest I. Rape in Congo is not a myth – if anything, it is under-reported. The Guardian. http://www.guardian.co.uk/commentisfree/2012/nov/21/rape-congo-not-myth-under-reported, 2012.
  • Zabarenko D. Countries must plan for climate refugees: report. Reuter. http://www.reuters.com/assets/print?aid=USTRE79Q6TS20111027, 2011.
  • Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, et al, International AIDS Society Scientific Working Group on HIV Cure. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012; 12:607 - 14; http://dx.doi.org/10.1038/nri3262; PMID: 22814509
  • Deeks SG. Determinants of virological response to antiretroviral therapy: implications for long-term strategies. Clin Infect Dis 2000; 30:Suppl 2 S177 - 84; http://dx.doi.org/10.1086/313855; PMID: 10860903
  • Veazey RS, Mansfield KG, Tham IC, Carville AC, Shvetz DE, Forand AE, et al. Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 2000; 74:11001 - 7; http://dx.doi.org/10.1128/JVI.74.23.11001-11007.2000; PMID: 11069995
  • Kewenig S, Schneider T, Hohloch K, Lampe-Dreyer K, Ullrich R, Stolte N, et al. Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999; 116:1115 - 23; http://dx.doi.org/10.1016/S0016-5085(99)70014-4; PMID: 10220503
  • Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284:816 - 9; http://dx.doi.org/10.1126/science.284.5415.816; PMID: 10221916
  • Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12:289 - 95; http://dx.doi.org/10.1038/nm1380; PMID: 16520776
  • Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, et al, RV254/SEARCH 010 Study Group. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012; 7:e33948; http://dx.doi.org/10.1371/journal.pone.0033948; PMID: 22479485
  • Lange CG, Lederman MM, Medvik K, Asaad R, Wild M, Kalayjian R, et al. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 2003; 17:2015 - 23; http://dx.doi.org/10.1097/00002030-200309260-00002; PMID: 14502004
  • Price P, Keane NM, Lee S, Lim AF, McKinnon EJ, French MAA. A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy. Immunology 2006; 119:74 - 82; http://dx.doi.org/10.1111/j.1365-2567.2006.02407.x; PMID: 16792698
  • Gahery H, Daniel N, Charmeteau B, Ourth L, Jackson A, Andrieu M, et al. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine. AIDS Res Hum Retroviruses 2006; 22:684 - 94; http://dx.doi.org/10.1089/aid.2006.22.684; PMID: 16831093
  • Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46:Suppl 1 S3 - 8; http://dx.doi.org/10.1097/01.qai.0000286597.57066.2b; PMID: 17713423
  • García F, Climent N, Guardo AC, Gil C, León A, Autran B, et al, DCV2/MANON07-ORVACS Study Group. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med 2013; 5:ra2; http://dx.doi.org/10.1126/scitranslmed.3004682; PMID: 23283367
  • Valor L, Navarro J, Carbone J, Rodríguez-Sáinz C, Gil J, López F, et al, STIR-2102 Team. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. Vaccine 2008; 26:2738 - 45; http://dx.doi.org/10.1016/j.vaccine.2008.03.019; PMID: 18433946
  • Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston MN, et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 2004; 200:701 - 12; http://dx.doi.org/10.1084/jem.20041270; PMID: 15381726
  • Vajdy M, Baudner B, Del Giudice G, O’Hagan D. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza. Clin Immunol 2007; 123:166 - 75; http://dx.doi.org/10.1016/j.clim.2007.01.009; PMID: 17349825
  • Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, Newman FK. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J Infect Dis 1996; 173:285 - 90; http://dx.doi.org/10.1093/infdis/173.2.285; PMID: 8568287
  • Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214:231 - 41; http://dx.doi.org/10.1002/path.2276; PMID: 18161758
  • Costiniuk CT, Angel JB. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?. Mucosal Immunol 2012; 5:596 - 604; http://dx.doi.org/10.1038/mi.2012.82; PMID: 22929559
  • Fujihashi K, Kiyono H. Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 2009; 30:334 - 43; http://dx.doi.org/10.1016/j.it.2009.04.004; PMID: 19540811
  • Bergquist C, Johansson EL, Lagergård T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997; 65:2676 - 84; PMID: 9199436
  • Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32:1605 - 13; http://dx.doi.org/10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; PMID: 12115643
  • van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007; 212:475 - 90; http://dx.doi.org/10.1016/j.imbio.2007.03.009; PMID: 17544832
  • Kaech SM, Ahmed R. Immunology. CD8 T cells remember with a little help. Science 2003; 300:263 - 5; http://dx.doi.org/10.1126/science.1084511; PMID: 12690179
  • Nakanishi Y, Lu B, Gerard C, Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009; 462:510 - 3; http://dx.doi.org/10.1038/nature08511; PMID: 19898495
  • Collette Y, Dutartre H, Benziane A, Olive D. The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck. Res Virol 1997; 148:52 - 8; http://dx.doi.org/10.1016/S0923-2516(97)81914-0; PMID: 9017835
  • Blazevic V, Heino M, Lagerstedt A, Ranki A, Krohn KJ. Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:208 - 14; http://dx.doi.org/10.1097/00042560-199611010-00002; PMID: 8898665
  • Quaranta MG, Mattioli B, Giordani L, Viora M. The immunoregulatory effects of HIV-1 Nef on dendritic cells and the pathogenesis of AIDS. FASEB J 2006; 20:2198 - 208; http://dx.doi.org/10.1096/fj.06-6260rev; PMID: 17077296
  • Clayden P, Collins S, Daniels C, Geffen N, Harrington M, Jefferys R, et al. Pipeline Report In: Benzacar A, ed. New York: Treatment Action Group, 2012.
  • Shete A, Thakar M, Singh DP, Gangakhedkar R, Gaikwad A, Pawar J, et al. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations. AIDS Res Hum Retroviruses 2012; 28:835 - 43; http://dx.doi.org/10.1089/aid.2010.0363; PMID: 21936714
  • Hoffmann D, Seebach J, Cosma A, Goebel FD, Strimmer K, Schätzl HM, et al. Therapeutic vaccination reduces HIV sequence variability. FASEB J 2008; 22:437 - 44; http://dx.doi.org/10.1096/fj.06-7975com; PMID: 17932027
  • Kutzler MA, Jacobson JM. Treatment interruption as a tool to measure changes in immunologic response to HIV-1. Curr Opin HIV AIDS 2008; 3:131 - 5; http://dx.doi.org/10.1097/COH.0b013e3282f54cde; PMID: 19372954
  • Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, et al, PLATO Collaboration. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 2004; 364:51 - 62; http://dx.doi.org/10.1016/S0140-6736(04)16589-6; PMID: 15234856
  • Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al, Rakai Project Team. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149 - 53; http://dx.doi.org/10.1016/S0140-6736(00)04331-2; PMID: 11323041
  • Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al, Women and Infants Transmission Study Group. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999; 341:394 - 402; http://dx.doi.org/10.1056/NEJM199908053410602; PMID: 10432324
  • Iglesias E, Thompson R, Carrazana Y, Lobaina Y, García D, Sánchez J, et al. Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1. Immunol Cell Biol 2006; 84:174 - 83; http://dx.doi.org/10.1111/j.1440-1711.2005.01408.x; PMID: 16519735
  • Iglesias E, García D, Carrazana Y, Aguilar JC, Sánchez A, Gorobaya L, et al. Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation. Curr HIV Res 2008; 6:452 - 60; http://dx.doi.org/10.2174/157016208785861186; PMID: 18855656
  • García-Díaz D, Rodríguez I, Santisteban Y, Márquez G, Terrero Y, Brown E, et al. Th2-Th1 shift with the multiantigenic formulation TERAVAC-HIV-1 in Balb/c mice. Immunol Lett 2013; 149:77 - 84; http://dx.doi.org/10.1016/j.imlet.2012.11.007; PMID: 23183092
  • Schirmbeck R, Böhm W, Melber K, Reimann J. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol 1995; 155:4676 - 84; PMID: 7594467
  • Milich DR, Chen M, Schödel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 1997; 94:14648 - 53; http://dx.doi.org/10.1073/pnas.94.26.14648; PMID: 9405667
  • Cao T, Lazdina U, Desombere I, Vanlandschoot P, Milich DR, Sällberg M, et al. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model. J Virol 2001; 75:6359 - 66; http://dx.doi.org/10.1128/JVI.75.14.6359-6366.2001; PMID: 11413302
  • Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpens P, Peterson DL, et al. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol 2001; 75:6367 - 74; http://dx.doi.org/10.1128/JVI.75.14.6367-6374.2001; PMID: 11413303
  • Lazdina U, Alheim M, Nyström J, Hultgren C, Borisova G, Sominskaya I, et al. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol 2003; 84:139 - 46; http://dx.doi.org/10.1099/vir.0.18678-0; PMID: 12533710
  • Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 1990; 345:258 - 60; http://dx.doi.org/10.1038/345258a0; PMID: 2110296
  • Steers NJ, Currier JR, Kijak GH, di Targiani RC, Saxena A, Marovich MA, et al. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire. J Virol 2011; 85:1541 - 53; http://dx.doi.org/10.1128/JVI.01790-10; PMID: 21106750
  • Iglesias E, Ruiz M, Carrazana Y, Cruz LJ, Aguilar A, Jimenez V, et al. Chimeric Proteins Containing HIV-1 T Cell Epitopes: Expression in E. Coli, Purification and Induction of Antibodies in Mice. J Biochem Mol Biol Biophys 2001; 5:109 - 22
  • Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res 2010; 85:303 - 15; http://dx.doi.org/10.1016/j.antiviral.2009.10.021; PMID: 19887087

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.